Consistent with these observations, mutations in TP53 (54%), APC (10%), SMAD4 (5.9%), KRAS (5.9%), and PIK3CA (5.1%) were present at a high rate in a large cohort of 666 specimens of GC [42]. This evidence concerns the gene SMAD4 and gastric cancer.